Hu Y; Xu F; Xing L; Feng Y; Rong K; Song J; Zheng S; Zeng S; Tan Y; Chen Q; Zhuang P · 2026 · Journal of voice : official journal of the Voice Foundation
Paper
OBJECTIVES: Laryngeal dystonia (LD) is a voice motor disorder involving multilevel central networks. Existing LD functional magnetic resonance imaging (fMRI) studies use heterogeneous region-of-interest (ROI) definitions and parcellation schemes, limiting comparability and reproducibility. To provide a more consistent framework for ROI definition and whole-brain network-level analysis, we aimed to develop and technically validate a standardized, small-structure-preserving whole-brain ROI atlas for LD fMRI research. METHODS: We integrated Automated Anatomical Labeling version 1 (AAL1)-derived cerebral and selected subcortical regions, the Spatially Unbiased Infratentorial Template (SUIT) cerebellar atlas, the Najdenovska thalamic nuclei atlas, and Brainstem Navigator-derived diencephalic and brainstem regions. Atlases were harmonized to Montreal Neurological Institute (MNI) space with nearest-neighbor interpolation and small-structure-prioritized merging, generating a 1-mm reference atlas (LD-208) and a 2-mm fMRI-ready atlas (LD-205). Quality control included ROI continuity, zero-voxel checks, voxel counts, connected components, and source tracing. LD-205 was tested in resting-state fMRI data from 10 healthy participants. RESULTS: LD-208 and LD-205 contained 208 and 205 ROIs, respectively. Compared with LD-208, LD-205 did not retain three extremely small brainstem ROIs on the 2-mm grid. Both atlases had continuous ROI numbering and no zero-voxel ROIs. All LD-205 ROIs yielded valid voxels, mean blood oxygen level-dependent (BOLD) time series, and complete 205 × 205 connectivity matrices in every participant. CONCLUSIONS: LD-208 and LD-205 provide traceable and quality-controlled whole-brain ROI frameworks for LD-oriented fMRI research. The technical validation demonstrates the feasibility of applying LD-205 to conventional resting-state fMRI data and supports its use as a standardized ROI framework for future disease-specific studies.
Analysis
Preparing paper insights from the available abstract and paper details.
Discovery
Yang Z; Chang X; Chen J; Pei H; Liao J; Luo X; He H; Duan M; Rodriguez-Labrada R; Jiang S; Yao D; Luo C
Yingxu Wang; Kunyu Zhang; Yanwu Yang3; Thomas Wolfers; Yujie Wu; Siyang Gao; Nan Yin
Thomas Jacquemont-Fulneau; Annibale Antonioni; Lina Daghsen; Justine Bouvier; Caroline Legendre; Rosso Charlotte
Fabian Leander Sinzinger; Sanna Persson; Marvin Köpff; Joana B. Pereira; Rodrigo Moreno
Przywara D; Petniak A; Gil-Kulik P
Park J; Borzin M
Source record